JFG
STLNW

Jefferies Financial Group’s Starling Oncology Warrant STLNW Stock Holding History

Jefferies Financial Group’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-95,000
Closed -$8.73K – 2000
2023
Q3 		$8.73K Hold
95,000
– – ﹤0.01% 1546
2023
Q2 		$2.65K Hold
95,000
– – ﹤0.01% 1604
2023
Q1 		$9.01K Hold
95,000
– – ﹤0.01% 1555
2022
Q4 		$10.5K Buy
+95,000
New +$31K ﹤0.01% 1476

Other funds holding STLNW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Jefferies Financial Group's STLNW Position: Q4 2023 in Review

Jefferies Financial Group sold out of Starling Oncology Warrant (STLNW) in Q4 2023, closing a stake of 95,000 shares — an estimated $8.73K sold.

Jefferies Financial Group first reported a position in STLNW in Q4 2022 and held it in 4 quarters. The position peaked at $10.5K in Q4 2022. 16 funds tracked by Wall St. Rank hold STLNW as of Q4 2023.

  • Jefferies Financial Group reported no remaining Starling Oncology Warrant position as of Q4 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 95,000 Starling Oncology Warrant shares in Q4 2023, an estimated $8.73K.
  • Jefferies Financial Group first reported a position in Starling Oncology Warrant in Q4 2022 and held it in 4 quarters.
  • Jefferies Financial Group's Starling Oncology Warrant position peaked at $10.5K in Q4 2022.
  • 16 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q4 2023.

Based on Jefferies Financial Group's 13F filing for Q4 2023, filed 14 Feb 2024.